Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
- Resource Type
- Article
- Source
- In
Annals of Oncology July 2012 23(7):1744-1750 - Subject
- Language
- ISSN
- 0923-7534